Precision Optics Corporat... (POCI)
undefined
undefined%
At close: undefined
5.10
0.39%
After-hours Dec 13, 2024, 03:59 PM EST

Company Description

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area.

It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.

The company also provides components and assemblies for industrial and military use.

It markets its products to medical device companies.

The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Precision Optics Corporation Inc.
Precision Optics Corporation Inc. logo
Country United States
IPO Date Jan 16, 1992
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 83
CEO Dr. Joseph N. Forkey

Contact Details

Address:
22 East Broadway
Gardner, Massachusetts
United States
Website https://www.poci.com

Stock Details

Ticker Symbol POCI
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000867840
CUSIP Number 740294400
ISIN Number US7402944000
Employer ID 04-2795294
SIC Code 3845

Key Executives

Name Position
Dr. Joseph N. Forkey Chief Executive Officer, President, Treasurer & Director
Richard E. Forkey Founder, Advisor to the Chief Executive Officer & Director Emeritus
Mahesh Lawande Chief Operating Officer
Wayne M. Coll Chief Financial Officer & Secretary
Clay Schwabe Vice President of Sales & Marketing
Divaker Mangadu President of Ross Optical Division
Stephanie R. Hansen Director of Human Resources

Latest SEC Filings

Date Type Title
Nov 22, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 14, 2024 10-Q Quarterly Report
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 28, 2024 10-K/A [Amend] Annual Report
Oct 28, 2024 4 Filing
Oct 01, 2024 8-K Current Report